FTSE 100 falls as rising oil prices and gilt yields weigh on sentiment

FTSE 100
  • FTSE 100: 9,886.42, -0.86%
  • GBP/USD: 1.33006
  • GBP/EUR: 1.15560
  • Brent crude: $110.75 per barrel, +4.53%
  • Gold: $4,409.56 per troy ounce, +0.61%
  • UK 10-year gilt yield: 5.033%

The FTSE 100 moved lower on Friday morning, falling 0.86% to 9,886.42 as a sharp rise in oil prices and a further increase in gilt yields weighed on market sentiment. Investors faced a tougher macro backdrop, with higher energy costs adding to inflation concerns and bond markets signalling tighter financial conditions.

What’s driving markets today

  1. Brent crude has climbed to $110.75 per barrel, increasing concern that higher energy prices could add to inflation pressure.
  2. The UK 10-year gilt yield has risen to 5.033%, which creates a more difficult backdrop for equity valuations.
  3. The combination of higher oil and higher yields has weakened broader risk appetite.
  4. Gold remains firm above $4,400 per troy ounce, suggesting that defensive positioning is still present in the market.

FTSE 100 performance breakdown

The FTSE 100’s decline reflects renewed pressure from macro factors rather than a single company-specific catalyst. Higher oil prices can feed directly into inflation expectations, which matters because it may keep interest rates elevated for longer. At the same time, a rise in gilt yields tends to reduce the relative appeal of equities by increasing the discount rate applied to future earnings.

That combination has weighed on sentiment across rate-sensitive and cyclical areas of the market. While the FTSE 100 retains exposure to large international businesses and defensive sectors, that support was not enough to offset the drag from weaker industrial, mining and property-related names. The market tone suggests investors are becoming more cautious as financing conditions tighten.

Top Risers

  • 3i Group rose 3.57% to 2,381.00p, among the leading gainers.
  • AstraZeneca gained 2.99% to 14,244.00p, among the leading gainers.
  • RELX rose 0.96% to 2,421.00p, among the leading gainers.
  • Experian added 0.94% to 2,569.00p, among the leading gainers.
  • Smith & Nephew gained 0.84% to 1,205.50p, among the leading gainers.
  • The Sage Group rose 0.66% to 820.00p, among the leading gainers.

Top Fallers

  • Metlen Energy & Metals fell 5.61% to €32.80, among the leading fallers.
  • Rolls-Royce Holdings declined 2.83% to 1,117.50p, among the leading fallers.
  • Entain dropped 2.74% to 539.40p, among the leading fallers.
  • Antofagasta fell 2.71% to 3,158.00p, among the leading fallers.
  • SEGRO slipped 2.48% to 636.00p, among the leading fallers.
  • Barratt Redrow declined 2.46% to 261.70p, among the leading fallers.

Sector Overview

The day’s mover list points to a defensive bias in relative performance. Healthcare, information services and software names featured among the risers, while more cyclical or rate-sensitive stocks came under pressure. Property and housebuilding names weakened as higher gilt yields worsened the interest-rate backdrop, while mining stocks also lost ground.

Macro sensitivity

The FTSE 100 remains highly sensitive to shifts in commodity prices and bond yields. A move higher in oil raises inflation concerns, while higher gilt yields put pressure on valuations and borrowing-sensitive sectors. A relatively stable pound offers limited relief when the broader macro picture is deteriorating.

Risks to watch

  • Further increases in oil prices could intensify inflation concerns.
  • Rising gilt yields may continue to pressure valuations across the market.
  • Persistent strength in gold could indicate that investors remain defensive.
  • Any further deterioration in risk appetite could weigh on cyclical sectors.

Outlook

The near-term direction for the FTSE 100 is likely to depend on whether oil prices stabilise and whether gilt yields begin to ease. If both remain elevated, the market may struggle to regain momentum. Investors will also be watching whether defensive leadership continues, as that would point to ongoing caution beneath the surface of the index.

Investor Takeaway

The FTSE 100 is under pressure from a more difficult macro backdrop, with higher oil prices and bond yields driving the market narrative. For investors, the key question is whether these pressures prove temporary or develop into a more persistent headwind for UK equities.

Share on:

Vietnam Enterprise Investments earnings strengthen as investor flows weigh on stocks

VEIL’s portfolio manager examines the disconnect between strong corporate earnings and weak share prices, and why easing inflation, improving liquidity and Vietnam’s FTSE upgrade could help narrow the gap.

Chesnara reports 79% rise in operating capital generation in H1 2026

Chesnara delivered strong first-half growth, with operating capital generation up 79% to £96m, adjusted operating profit rising 46% and the interim dividend increasing 6%.

Oxford Nanopore appoints David Miller as Chief Development and Product Officer

Oxford Nanopore Technologies has appointed David Miller as Chief Development and Product Officer and confirmed Conor McKechnie as Chief Marketing and Communications Officer. The new executive hires, both joining the leadership team this autumn, are intended to align product development, marketing and commercial execution as the company scales its differentiated technology platform.

Smiths Group appoints two independent Non-Executive Directors

Smiths Group has announced the appointment of Val Rahmani and Emma FitzGerald as independent non-executive directors, with committee changes also confirmed.

Melrose Industries announces claims programme and GKN Garden Grove restart target

Melrose Industries has outlined a claims programme, regulatory update and target date for full manufacturing operations at GKN Aerospace Garden Grove.

AstraZeneca strengthens funding position with €2.55 billion Eurobond issue

AstraZeneca has priced four tranches of Eurobonds totalling €2.55 billion, with closing expected on 1 September 2026.

Natural gas outlook strengthens as heat and LNG demand tighten market balance

US natural gas is entering a stronger seasonal setup as heat, slower storage growth and recovering LNG demand improve the market balance.

GSK gains priority FDA review for Jemperli in rectal cancer

GSK says the US FDA has accepted Jemperli for priority review in previously untreated stage II and III locally advanced rectal cancer.

Search

Search